Full Text View
Tabular View
No Study Results Posted
Related Studies
Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug (VITOBA)
This study is ongoing, but not recruiting participants.
Study NCT01098162   Information provided by UCB, Inc.

First Received on April 1, 2010.   Last Updated on May 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsies, Partial
Additional conditions recognized in this trial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Additional drug interventions recognized in this trial
Anticonvulsants
More general drug interventions related to this trial
Central Nervous System Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
UCB Pharma GmbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services